花园生物
(300401)
| 流通市值：72.81亿 | | | 总市值：74.02亿 |
| 流通股本：5.35亿 | | | 总股本：5.43亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 935,701,786.71 | 635,361,170.79 | 326,391,133.03 | 1,243,283,228.76 |
| 营业收入 | 935,701,786.71 | 635,361,170.79 | 326,391,133.03 | 1,243,283,228.76 |
| 二、营业总成本 | 681,596,217.82 | 464,449,150.95 | 225,274,384.48 | 952,332,834.6 |
| 营业成本 | 418,730,351.87 | 279,912,545.19 | 140,990,085.57 | 516,751,694.83 |
| 税金及附加 | 14,593,212.62 | 12,644,917.75 | 4,542,782.79 | 23,072,483 |
| 销售费用 | 115,838,645.93 | 81,950,539.28 | 36,903,134.01 | 193,576,190.68 |
| 管理费用 | 69,298,156.54 | 48,682,514.49 | 22,790,616.72 | 115,796,934.93 |
| 研发费用 | 47,239,313.67 | 32,926,037.33 | 16,376,140.28 | 83,778,120.03 |
| 财务费用 | 15,896,537.19 | 8,332,596.91 | 3,671,625.11 | 19,357,411.13 |
| 其中:利息费用 | 23,502,503.38 | 15,178,227.23 | 7,909,114.98 | 35,634,971.23 |
| 其中:利息收入 | 6,159,974.93 | 4,009,489.84 | 1,867,757.07 | 10,291,003.7 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 2,633,331.51 | 1,957,663.02 | 1,000,109.59 | 245,210.96 |
| 加:投资收益 | 756,809.35 | 181,778.62 | - | 716,902.82 |
| 资产处置收益 | -2,131,924.97 | 159.58 | 183.12 | 31,530,438.85 |
| 资产减值损失(新) | -1,882,107.46 | -1,482,482.08 | - | -2,505,142.09 |
| 信用减值损失(新) | -2,358,275.57 | -1,171,076.19 | -983,515.72 | -1,974,128.16 |
| 其他收益 | 13,229,770.66 | 8,893,250.81 | 5,224,300.96 | 36,435,671.31 |
| 四、营业利润 | 264,353,172.41 | 179,291,313.6 | 106,357,826.5 | 355,399,347.85 |
| 加:营业外收入 | 6,109,956.95 | 6,167,983.43 | 5,467,820.28 | 4,232,319.77 |
| 减:营业外支出 | 1,635,118.41 | 82,423.02 | 75,964.43 | 938,247.5 |
| 五、利润总额 | 268,828,010.95 | 185,376,874.01 | 111,749,682.35 | 358,693,420.12 |
| 减:所得税费用 | 34,773,392.18 | 23,833,026.52 | 15,239,841.24 | 49,484,432.1 |
| 六、净利润 | 234,054,618.77 | 161,543,847.49 | 96,509,841.11 | 309,208,988.02 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 234,054,618.77 | 161,543,847.49 | 96,509,841.11 | 309,208,988.02 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 234,059,386.22 | 161,547,089.8 | 96,511,379.04 | 309,212,798.15 |
| 少数股东损益 | -4,767.45 | -3,242.31 | -1,537.93 | -3,810.13 |
| 扣除非经常损益后的净利润 | 221,230,043.59 | 149,525,626.58 | 88,138,393.32 | 256,888,423.11 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.43 | 0.3 | 0.18 | 0.57 |
| (二)稀释每股收益 | 0.4 | 0.28 | 0.18 | 0.52 |
| 九、综合收益总额 | 234,054,618.77 | 161,543,847.49 | 96,509,841.11 | 309,208,988.02 |
| 归属于母公司股东的综合收益总额 | 234,059,386.22 | 161,547,089.8 | 96,511,379.04 | 309,212,798.15 |
| 归属于少数股东的综合收益总额 | -4,767.45 | -3,242.31 | -1,537.93 | -3,810.13 |
| 公告日期 | 2025-10-18 | 2025-08-16 | 2025-04-18 | 2025-03-25 |
| 审计意见(境内) | | | | 标准无保留意见 |